According to the possible mechanism by which CD11b+ TIM suppresses the tumoricidal effect of CD8+ TILs, CD11b+ myeloid-derived suppressor cells regulate the entry of activated CD8+ TILs into the tumor site. The gene discussed is ITGAM; the disease is neoplasm.